Educational content on VJNeurology is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

Share this video  

EAN 2022 | Therapy relevant pathomechanisms in neuroimmunology

Hans Lassmann • 27 Jun 2022
EAN 2022
Multiple Sclerosis and Related Disorders

The neuroimmunology field has witnessed a revolution in the last decade, novel diseases have been identified, and many treatments have been developed. Hans Lassmann, MD, Medical University of Vienna, Vienna, Austria, outlines the importance of a comprehensive understanding of the basic immunological mechanisms involved in the pathogenesis of the disease for proper individual therapy and the development of novel treatment strategies. This interview took place at the 2022 Congress of the European Academy of Neurology (EAN) in Vienna, Austria.

More from Hans Lassmann

2:01
MS & MOGAD: differences in response to immunomodulatory therapies
Hans Lassmann • 27 Oct 2022
1:49
The pathology of MS and MOGAD: similarities and differences
Hans Lassmann • 27 Oct 2022
2:55
The immune mechanisms behind neurodegeneration in progressive MS
Hans Lassmann • 27 Oct 2022
2:03
The role of Epstein-Barr virus in the pathogenesis of MS
Hans Lassmann • 27 Oct 2022

Related Videos

3:44
Navigating intra-individual variability for early detection of cognitive decline
Leigh Charvet • 23 Feb 2024
5:42
Mapping the functional interactome in MS lesions to shed light on remyelination failure
Milos Opacic • 5 Mar 2024
3:26
Acupressure for the management of pain and anxiety in patients with MS
Megan Weigel • 4 Mar 2024
5:37
GAIT-HUB: a home-based gait monitoring system for patients with MS
Giuseppina Pilloni • 4 Mar 2024
The content of VJNeurology is intended for healthcare professionals